Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease
- PMID: 29507413
- PMCID: PMC6124498
- DOI: 10.1038/s41593-018-0101-9
Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease
Erratum in
-
Publisher Correction: Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease.Nat Neurosci. 2018 Jul;21(7):1018. doi: 10.1038/s41593-018-0124-2. Nat Neurosci. 2018. PMID: 29556027
Abstract
Aging is the strongest risk factor for Alzheimer's disease (AD), although the underlying mechanisms remain unclear. The chromatin state, in particular through the mark H4K16ac, has been implicated in aging and thus may play a pivotal role in age-associated neurodegeneration. Here we compare the genome-wide enrichment of H4K16ac in the lateral temporal lobe of AD individuals against both younger and elderly cognitively normal controls. We found that while normal aging leads to H4K16ac enrichment, AD entails dramatic losses of H4K16ac in the proximity of genes linked to aging and AD. Our analysis highlights the presence of three classes of AD-related changes with distinctive functional roles. Furthermore, we discovered an association between the genomic locations of significant H4K16ac changes with genetic variants identified in prior AD genome-wide association studies and with expression quantitative trait loci. Our results establish the basis for an epigenetic link between aging and AD.
Conflict of interest statement
The authors declare no competing interests.
Figures






Comment in
-
Alzheimer disease: Epigenetics links ageing with Alzheimer disease.Nat Rev Neurol. 2018 May;14(5):254. doi: 10.1038/nrneurol.2018.36. Epub 2018 Mar 23. Nat Rev Neurol. 2018. PMID: 29569623 No abstract available.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous